Preprint Article Version 1 This version is not peer-reviewed

The Improvement of Adaptive Immune Responses towards COVID-19 Following Diphtheria-Tetanus-Pertussis and SARS-CoV-2 Vaccinations in Indonesian Children: Exploring Roles of Heterologous Immunity

Version 1 : Received: 12 July 2024 / Approved: 15 July 2024 / Online: 17 July 2024 (04:12:51 CEST)

How to cite: Santi, T.; Jo, J.; Harahap, A. R.; Werdhani, R. A.; Hadinegoro, S. R. S.; SahBandar, I. N.; Prayitno, A.; Munasir, Z.; Vandenplas, Y.; Hegar, B. The Improvement of Adaptive Immune Responses towards COVID-19 Following Diphtheria-Tetanus-Pertussis and SARS-CoV-2 Vaccinations in Indonesian Children: Exploring Roles of Heterologous Immunity. Preprints 2024, 2024071236. https://doi.org/10.20944/preprints202407.1236.v1 Santi, T.; Jo, J.; Harahap, A. R.; Werdhani, R. A.; Hadinegoro, S. R. S.; SahBandar, I. N.; Prayitno, A.; Munasir, Z.; Vandenplas, Y.; Hegar, B. The Improvement of Adaptive Immune Responses towards COVID-19 Following Diphtheria-Tetanus-Pertussis and SARS-CoV-2 Vaccinations in Indonesian Children: Exploring Roles of Heterologous Immunity. Preprints 2024, 2024071236. https://doi.org/10.20944/preprints202407.1236.v1

Abstract

Background: Routine childhood vaccination, e.g., for diphtheria-tetanus-pertussis (DTP), might provide an additional protection towards SARS-CoV-2 infection. This concept of heterologous immunity was explored in healthy children receiving both DTP and inactivated SARS-CoV-2 vaccines. Methods: A cross-sectional study was performed on 154 healthy children aged 6–8 years old in Jakarta, Indonesia. Their vaccination status of DTP (including diphtheria-tetanus booster vac-cine at 5 years old) and CoronaVac (from 6 years old) were recorded. Peripheral blood samples were collected from all participants, in which anti-diphtheria toxoid IgG, anti-SARS-CoV-2 S-RBD antibodies and T cell-derived IFN- were measured. Results: Study participants with complete DTP vaccination had significantly higher titer of an-ti-diphtheria toxoid IgG than the ones without (median=0.9349 versus 0.2113 IU/mL; p

Keywords

Children; SARS-CoV-2-specific immune response; Heterologous immunity; Diphtheria-tetanus-pertussis vaccine; Inactivated COVID-19 vaccine

Subject

Medicine and Pharmacology, Immunology and Allergy

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.